
### [NCIT:C39851](http://purl.obolibrary.org/obo/NCIT_C39851)
**Label:** Bladder Urothelial Carcinoma

**Subclasses:** [NCIT:C27885](http://purl.obolibrary.org/obo/NCIT_C27885) (Infiltrating Bladder Urothelial Carcinoma), [NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant), [NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells), [NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C8940](http://purl.obolibrary.org/obo/NCIT_C8940) (Stage III Bladder Urothelial Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C8941](http://purl.obolibrary.org/obo/NCIT_C8941) (Stage IV Bladder Urothelial Carcinoma), [NCIT:C27634](http://purl.obolibrary.org/obo/NCIT_C27634) (Transplant-Related Bladder Urothelial Carcinoma), [NCIT:C7383](http://purl.obolibrary.org/obo/NCIT_C7383) (Bladder Papillary Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C6191](http://purl.obolibrary.org/obo/NCIT_C6191) (Stage I Bladder Urothelial Carcinoma), [NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant), [NCIT:C126307](http://purl.obolibrary.org/obo/NCIT_C126307) (Recurrent Bladder Urothelial Carcinoma), [NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements), [NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements), [NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation), [NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation), [NCIT:C39844](http://purl.obolibrary.org/obo/NCIT_C39844) (Bladder Urachal Urothelial Carcinoma), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), [NCIT:C8939](http://purl.obolibrary.org/obo/NCIT_C8939) (Stage II Bladder Urothelial Carcinoma), [NCIT:C39824](http://purl.obolibrary.org/obo/NCIT_C39824) (Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant), 

**Class expressions from DL-Learner:**

- Thing 55.46%
- [NCIT:C41454](http://purl.obolibrary.org/obo/NCIT_C41454) (Cystic Change) 53.33%
- [NCIT:C54565](http://purl.obolibrary.org/obo/NCIT_C54565) (Preserved Nuclear Polarity) 51.11%
- [NCIT:C54560](http://purl.obolibrary.org/obo/NCIT_C54560) (Human Chorionic Gonadotropin Positive Neoplastic Cells Present) 51.11%
- [NCIT:C54559](http://purl.obolibrary.org/obo/NCIT_C54559) (Heterologous Elements Present) 51.11%
- [NCIT:C41464](http://purl.obolibrary.org/obo/NCIT_C41464) (Macrocystic Change) 51.11%
- [NCIT:C41456](http://purl.obolibrary.org/obo/NCIT_C41456) (Microcystic Change) 51.11%
- [NCIT:C41428](http://purl.obolibrary.org/obo/NCIT_C41428) (Increased Cellularity Present) 51.11%
- [NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q) 51.11%
- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 51.11%
- [NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation) 51.11%
- [NCIT:C36681](http://purl.obolibrary.org/obo/NCIT_C36681) (MDM2 Gene Amplification) 51.11%
- [NCIT:C36679](http://purl.obolibrary.org/obo/NCIT_C36679) (HRAS Gene Amplification) 51.11%
- [NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification) 51.11%
- [NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification) 51.11%


